DURHAM, N.C., June 5, 2014 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq:ARGS), a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, today announced that the Company will host a conference call and webcast on Monday, June 9, 2014 at 1 p.m. EDT. Robert A. Figlin, MD, FACP, professor of medicine and biomedical sciences, director of the Division of Hematology Oncology and deputy director at Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute, along with Douglas C. Plessinger, RPh, Argos’ vice president of clinical and medical affairs, will participate in the call to discuss data recently presented in mRCC at the 2014 ASCO annual meeting held in Chicago, IL from May 30 – June 3, 2014.
Help employers find you! Check out all the jobs and post your resume.
